Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kumi Oshima

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2014
[Immunomodulatory drugs (IMiDs)]Kumi Oshima, Tatsuo Ichinohe
Case Reports in Nephrology and Dialysis|June 11, 2020
Cat Rearing: A Potential Risk of Fulminant Sepsis Caused by <i>Capnocytophaga canimorsus</i> in a Hemodialysis PatientJinichi Mori, Kumi Oshima, Tetsuya Tanimoto
Case Reports in Hematology|August 18, 2020
Treatment of T-Cell Prolymphocytic Leukemia with Central Nervous System Involvement Using Intrathecal Alemtuzumab AdministrationJinichi Mori, Kumi Oshima, Satoshi Kimura, et al.
Case Reports in Obstetrics and Gynecology|March 14, 2017
Prenatal and Peripartum Management of Patients with Hypofibrinogenemia Resulted in Two Successful DeliveriesYuko Teraoka, Hiroshi Miyoshi, Kumi Oshima, et al.
FEBS Letters|May 23, 2002
SHPS-1, a multifunctional transmembrane glycoproteinKumi Oshima, A R M Ruhul Amin, Atsushi Suzuki, et al.
International Journal of Hematology|March 11, 2020
Pharmacokinetics of dasatinib in a hemodialysis patient with chronic myeloid leukemia and chronic kidney diseaseJinichi Mori, Kumi Oshima, Tetsuya Tanimoto, et al.
Cancer Research|July 19, 2002
SHPS-1: a budding molecule against cancer disseminationKumi Oshima, Kazuya Machida, Yasukatu Ichigotani, et al.
International Journal of Hematology|August 14, 2023
Aortitis after administration of pegfilgrastim to a healthy donor for peripheral blood stem cell collectionYu Uemura, Kumi Oshima, Aika Fuseya, et al.
American Journal of Hematology|August 1, 2007
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantationShinichi Kako, Koji Izutsu, Kumi Oshima, et al.
BMC Nephrology|May 5, 2018
Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case reportShuma Hirashio, Ayaka Satoh, Takahiro Arima, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 15, 2014
[Immunomodulatory drugs (IMiDs)]Kumi Oshima, Tatsuo Ichinohe
Case Reports in Nephrology and Dialysis|June 11, 2020
Cat Rearing: A Potential Risk of Fulminant Sepsis Caused by <i>Capnocytophaga canimorsus</i> in a Hemodialysis PatientJinichi Mori, Kumi Oshima, Tetsuya Tanimoto
Case Reports in Hematology|August 18, 2020
Treatment of T-Cell Prolymphocytic Leukemia with Central Nervous System Involvement Using Intrathecal Alemtuzumab AdministrationJinichi Mori, Kumi Oshima, Satoshi Kimura, et al.
Case Reports in Obstetrics and Gynecology|March 14, 2017
Prenatal and Peripartum Management of Patients with Hypofibrinogenemia Resulted in Two Successful DeliveriesYuko Teraoka, Hiroshi Miyoshi, Kumi Oshima, et al.
FEBS Letters|May 23, 2002
SHPS-1, a multifunctional transmembrane glycoproteinKumi Oshima, A R M Ruhul Amin, Atsushi Suzuki, et al.
International Journal of Hematology|March 11, 2020
Pharmacokinetics of dasatinib in a hemodialysis patient with chronic myeloid leukemia and chronic kidney diseaseJinichi Mori, Kumi Oshima, Tetsuya Tanimoto, et al.
Cancer Research|July 19, 2002
SHPS-1: a budding molecule against cancer disseminationKumi Oshima, Kazuya Machida, Yasukatu Ichigotani, et al.
International Journal of Hematology|August 14, 2023
Aortitis after administration of pegfilgrastim to a healthy donor for peripheral blood stem cell collectionYu Uemura, Kumi Oshima, Aika Fuseya, et al.
American Journal of Hematology|August 1, 2007
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantationShinichi Kako, Koji Izutsu, Kumi Oshima, et al.
BMC Nephrology|May 5, 2018
Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case reportShuma Hirashio, Ayaka Satoh, Takahiro Arima, et al.
Pageof 7